Scott Henry
Stock Analyst at Alliance Global Partners
(1.65)
# 3,207
Out of 4,876 analysts
61
Total ratings
39.62%
Success rate
-4.63%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $0.95 | +214.91% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.94 | +93.80% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $3.28 | +82.93% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.25 | +207.69% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.65 | +323.92% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.13 | +19.21% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.30 | +207.69% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.79 | +737.99% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.34 | +3,401.60% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $7.70 | -2.60% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $13.57 | -4.17% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $26.54 | -9.55% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $114.28 | -21.25% | 9 | Dec 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $21.79 | -28.87% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $82.49 | -29.69% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $60.47 | -40.47% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $0.89 | +1,130.98% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.78 | +25.52% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $3.40 | +169,017.65% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.28 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $2.25 | +211.11% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $34.82 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.40 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $0.95
Upside: +214.91%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.94
Upside: +93.80%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $3.28
Upside: +82.93%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.65
Upside: +323.92%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.13
Upside: +19.21%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.30
Upside: +207.69%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.79
Upside: +737.99%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.34
Upside: +3,401.60%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $7.70
Upside: -2.60%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $13.57
Upside: -4.17%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $26.54
Upside: -9.55%
Dec 23, 2022
Maintains: Buy
Price Target: $85 → $90
Current: $114.28
Upside: -21.25%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $21.79
Upside: -28.87%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $82.49
Upside: -29.69%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $60.47
Upside: -40.47%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $0.89
Upside: +1,130.98%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.78
Upside: +25.52%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $3.40
Upside: +169,017.65%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.28
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $2.25
Upside: +211.11%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $34.82
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.40
Upside: -